Your browser doesn't support javascript.
loading
BTK drives neutrophil activation for sterilizing antifungal immunity.
Desai, Jigar V; Zarakas, Marissa A; Wishart, Andrew L; Roschewski, Mark; Aufiero, Mariano A; Donkó, Ágnes; Wigerblad, Gustaf; Shlezinger, Neta; Plate, Markus; James, Matthew R; Lim, Jean K; Uzel, Gulbu; Bergerson, Jenna Re; Fuss, Ivan; Cramer, Robert A; Franco, Luis M; Clark, Emily S; Khan, Wasif N; Yamanaka, Daisuke; Chamilos, Georgios; El-Benna, Jamel; Kaplan, Mariana J; Staudt, Louis M; Leto, Thomas L; Holland, Steven M; Wilson, Wyndham H; Hohl, Tobias M; Lionakis, Michail S.
Afiliação
  • Desai JV; Fungal Pathogenesis Section, LCIM, NIAID, NIH, Bethesda, United States of America.
  • Zarakas MA; Fungal Pathogenesis Section, LCIM, NIAID, NIH, Bethesda, United States of America.
  • Wishart AL; Fungal Pathogenesis Section, LCIM, NIAID, NIH, Bethesda, United States of America.
  • Roschewski M; Lymphoid Malignancies Branch, National Cancer Institute, NIH, Bethesda, United States of America.
  • Aufiero MA; Louis V. Gerstner Jr. Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, United States of America.
  • Donkó Á; Molecular Defenses Section, LCIM, NIAID, NIH, Bethesda, United States of America.
  • Wigerblad G; Systemic Autoimmunity Branch, NIAMS, NIH, Bethesda, United States of America.
  • Shlezinger N; Infectious Diseases, Memorial Sloan Kettering Cancer Center, New York, United States of America.
  • Plate M; Infectious Diseases, Memorial Sloan Kettering Cancer Center, New York, United States of America.
  • James MR; Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Hanover, United States of America.
  • Lim JK; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, United States of America.
  • Uzel G; Immunopathogenesis Section, LCIM, NIAID, NIH, Bethesda, United States of America.
  • Bergerson JR; Primary Immune Deficiency Clinic, LCIM, NIAID, NIH, Bethesda, United States of America.
  • Fuss I; Mucosal Immunity Section, LCIM, NIAID, NIH, Bethesda, United States of America.
  • Cramer RA; Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Hanover, United States of America.
  • Franco LM; Functional Immunogenomics Section, NIAMS, NIH, Bethesda, United States of America.
  • Clark ES; Microbiology and Immunology, Miller School of Medicine, University of Miami, Miami, United States of America.
  • Khan WN; Microbiology and Immunology, Miller School of Medicine, University of Miami, Miami, United States of America.
  • Yamanaka D; Laboratory for Immunopharmacology of Microbial Products, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan.
  • Chamilos G; Clinical Microbiology and Microbial Pathogenesis, University Hospital of Heraklion, Heraklion, Greece.
  • El-Benna J; Center for Research on Inflammation, City University of Paris, INSERM-U1149, CNRS-ERL8252, Paris, France.
  • Kaplan MJ; Systemic Autoimmunity Branch, NIAMS, NIH, Bethesda, United States of America.
  • Staudt LM; Lymphoid Malignancies Branch, National Cancer Institute, NIH, Bethesda, United States of America.
  • Leto TL; Molecular Defenses Section, LCIM, NIAID, NIH, Bethesda, United States of America.
  • Holland SM; Immunopathogenesis Section, LCIM, NIAID, NIH, Bethesda, United States of America.
  • Wilson WH; Lymphoid Malignancies Branch, National Cancer Institute, NIH, Bethesda, United States of America.
  • Hohl TM; Infectious Diseases, Memorial Sloan Kettering Cancer Center, New York, United States of America.
  • Lionakis MS; Fungal Pathogenesis Section, LCIM, NIAID, NIH, Bethesda, United States of America.
J Clin Invest ; 2024 May 02.
Article em En | MEDLINE | ID: mdl-38696257
ABSTRACT
We describe a previously-unappreciated role for Bruton's tyrosine kinase (BTK) in fungal immune surveillance against aspergillosis, an unforeseen complication of BTK inhibitors (BTKi) used for treating B-cell lymphoid malignancies. We studied BTK-dependent fungal responses in neutrophils from diverse populations, including healthy donors, BTKi-treated patients, and X-linked agammaglobulinemia patients. Upon fungal exposure, BTK was activated in human neutrophils in a TLR2-, Dectin-1-, and FcγR-dependent manner, triggering the oxidative burst. BTK inhibition selectively impeded neutrophil-mediated damage to Aspergillus hyphae, primary granule release, and the fungus-induced oxidative burst by abrogating NADPH oxidase subunit p40phox and GTPase RAC2 activation. Moreover, neutrophil-specific Btk deletion in mice enhanced aspergillosis susceptibility by impairing neutrophil function, not recruitment or lifespan. Conversely, GM-CSF partially mitigated these deficits by enhancing p47phox activation. Our findings underline the crucial role of BTK signaling in neutrophils for antifungal immunity and provide a rationale for GM-CSF use to offset these deficits in susceptible patients.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Clin Invest Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Clin Invest Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos